- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00370409
Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage
July 31, 2008 updated by: Shahid Beheshti University of Medical Sciences
Late vitreous hemorrhage in postvitrectomized diabetic eyes may be due to fibrovascular tuft formation in sclerotomy sites.
Cryotherapy of sclerotomy sites may prevent bleeding by regressing the fibrovascular tuft.
This study will detect the safety and efficacy of cryotherapy of sclerotomy sites for prevention of late vitreous hemorrhage in vitrectomized diabetic eyes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
112
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tehran, Iran, Islamic Republic of, 16666
- Ophthalmic Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diabetic retinopathy cases undergoing vitrectomy
Exclusion Criteria:
- History of deep vitrectomy or cataract surgery
- Renal failure
- Silicone oil injection during surgery
- Early rebleeding
- History of antithrombotic drugs usage
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: 2
|
Cryotherapy of both sides of sclerotomy sites was done for 6 seconds after complition of operation.
|
|
Experimental: 1
Cryotherapy
|
Cryotherapy of both sides of sclerotomy sites was done for 6 seconds after complition of operation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Prevention of late vitreous hemorrhage in postvitrectomized diabetic eyes
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of late vitreous hemorrhage in the cryo group.
Time Frame: 6 months
|
6 months
|
|
Incidence of late vitreous hemorrhage in the control group.
Time Frame: 6 months
|
6 months
|
|
Comparing incidence of late vitreous hemorrhage in both groups.
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Morteza Entezari, MD, Ophthalmic Research Center of Shaheed Beheshti Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2006
Primary Completion (Actual)
February 1, 2008
Study Completion (Actual)
June 1, 2008
Study Registration Dates
First Submitted
August 30, 2006
First Submitted That Met QC Criteria
August 30, 2006
First Posted (Estimate)
August 31, 2006
Study Record Updates
Last Update Posted (Estimate)
August 1, 2008
Last Update Submitted That Met QC Criteria
July 31, 2008
Last Verified
July 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8525
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Late Postvitrectomy Diabetic Hemorrhage.
-
Al Hadi HospitalCompletedDiabetic Vitreous HemorrhageKuwait
-
Panhandle Eye Group, LLPRecruitingDiabetic Vitreous HemorrhageMexico
-
Asan Medical CenterUnknownPost Vitrectomy State | Recurrent Diabetic Vitreous HemorrhageKorea, Republic of
-
Nihon UniversityCompletedProliferative Diabetic Retinopathy | Vitreous Hemorrhage | Diabetic Traction Retinal DetachmentJapan
-
Anders KvantaCompletedProliferative Diabetic RetinopathySweden
-
Rush Eye AssociatesActive, not recruitingProliferative Diabetic RetinopathyMexico
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); National Institutes of Health (NIH); Regeneron...CompletedProliferative Diabetic Retinopathy | Vitreous HemorrhageUnited States, Canada
-
Southeast Retina Center, GeorgiaUnknownProliferative Diabetic RetinopathyUnited States
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)CompletedProliferative Diabetic Retinopathy | Vitreous HemorrhageUnited States
-
Seoul National University Bundang HospitalCompletedProliferative Diabetic Retinopathy | Vitreous HemorrhageKorea, Republic of
Clinical Trials on Cryotherapy
-
University Hospital, LilleAlmirall, SASNot yet recruiting
-
Weill Medical College of Cornell UniversityProstate Cancer FoundationRecruiting
-
Cairo UniversityNot yet recruiting
-
Azienda Ospedaliera San Camillo ForlaniniCompleted
-
Hanyang University Seoul HospitalCompletedCryotherapy EffectKorea, Republic of
-
Creighton UniversityCompleted
-
Chung Shan Medical UniversityCompleted
-
Ondokuz Mayıs UniversityCompletedPain, Postoperative | Pulpitis | Caries; DentinTurkey (Türkiye)
-
Jonsson Comprehensive Cancer CenterCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate DiseaseUnited States
-
Stryker InstrumentsNorth American Science Associates Inc.Completed